U.S. Anatomic Pathology Market (By Product & Services: Instruments, Consumables, Services; By Application: Disease Diagnosis, Drug Discovery & Development; By End Use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2025-2034

U.S. Anatomic Pathology Market Size and Top Companies 

The U.S. anatomic pathology market size was accounted at USD 9.75 billion in 2024 and it is projected to hit around USD 19.54 billion by 2034, growing at a CAGR of 7.2% from 2025 to 2034. The market growth is driven by the rising prevalence of chronic diseases, growing demand for personalized medicine, and an increasing volume of diagnostic tests, the U.S. anatomic pathology market is experiencing steady growth.

Key Pointers

• By product and services, the consumables segment is generated the maximum market share of 69% in 2024.
• By product and services, the instruments segment is anticipated to grow at the noteworthy CAGR during the forecast period.
• By application, the disease diagnosis segment is registered the maximum market share in 2024. 
• By application, the drug discovery and development segment is estimated to expand the fastest CAGR from 2025 to 2034.
• By end use, the hospital segment captured the maximum market share in 2024. 
• By end use, the diagnostic laboratories segment is expected to grow at the notable CAGR during the forecast period. 

Report Scope of the U.S. Anatomic Pathology Market

U.S. Anatomic Pathology Market Overview 

The U.S. anatomic pathology market is witnessing steady growth, driven by the rising prevalence of chronic diseases, increasing cancer incidence, and the growing demand for early and accurate diagnostic techniques. Anatomic pathology plays a vital role in disease diagnosis, particularly in oncology, by enabling the examination of tissue samples to detect abnormalities at a cellular level. Technological advancements in digital pathology, automation, and molecular diagnostics are transforming traditional pathology practices, making processes more efficient and accurate. Moreover, the aging population, coupled with increased healthcare expenditure and a strong presence of leading diagnostic laboratories and healthcare infrastructure, further supports market expansion. 

What are the Growth Factors of U.S. Anatomic Pathology Market? 

One of the primary growth drivers of the U.S. anatomic pathology market is the rising burden of chronic diseases, especially cancer. As cancer remains a leading cause of death in the country, the need for accurate tissue-based diagnosis has become critical for effective treatment planning. Anatomic pathology plays a crucial role in cancer detection and staging, which has led to a surge in demand for pathology services across hospitals, diagnostic laboratories, and research institutions. 

Technological advancements are also significantly influencing the market's expansion. The integration of digital pathology, artificial intelligence (AI), and automation in laboratory processes is enhancing diagnostic accuracy, reducing turnaround time, and improving workflow efficiency. These innovations are enabling pathologists to handle higher volumes of complex cases with precision, thereby supporting broader adoption.

What are the Trends in U.S. Anatomic Pathology Market? 

• Adoption of Digital Pathology and AI: The integration of digital imaging and artificial intelligence is revolutionizing diagnostic accuracy and efficiency, enabling remote consultations and faster analysis of pathology slides.
• Shift Toward Personalized Medicine: Anatomic pathology is increasingly supporting precision medicine by identifying molecular and genetic markers, aiding in customized treatment plans for cancer and other complex diseases.
• Growing Demand for Outsourced Pathology Services: With rising case volumes and a shortage of skilled pathologists, many healthcare facilities are outsourcing pathology services to specialized labs, ensuring timely and high-quality diagnostics.

What are the Key Challenges Faced by U.S. Anatomic Pathology Market? 

One of the major challenges confronting the U.S. anatomic pathology market is the shortage of skilled pathologists and laboratory professionals. As the demand for diagnostic services continues to rise particularly with the increasing incidence of cancer and other chronic diseases the existing workforce is struggling to keep pace. This shortage leads to higher workloads, delayed diagnoses, and reduced efficiency, especially in smaller or rural healthcare settings. Additionally, the aging pathologist workforce raises concerns about long-term capacity and continuity of expertise in the field.

Another critical challenge is the high cost and complexity of adopting advanced technologies, such as digital pathology systems and AI-powered diagnostic tools. While these innovations offer improved accuracy and workflow benefits, their implementation requires substantial investment in infrastructure, software integration, data storage, and staff training. Smaller laboratories and community hospitals often face financial and operational barriers to adopting these technologies.

Segmental Insights

Product & Services Insights

The consumables segment held the largest market share, accounting for 69% in 2024. Consumables include reagents, staining solutions, fixatives, embedding materials, and antibodies used in histopathology and cytopathology. The frequent and recurring use of these materials in tissue processing, slide preparation, and staining makes them indispensable in pathology labs. The increasing volume of diagnostic testing, particularly for cancer and other chronic diseases, has led to a higher demand for high-quality consumables that ensure accuracy and reliability in results.
The instruments segment is expected to register the highest CAGR during the forecast period from 2025 to 2034.

The instruments segment is anticipated to register the highest CAGR during the forecast period from 2025 to 2034.
These include tissue processors, microtomes, slide strainers, embedding systems, and digital pathology scanners. The growing trend toward laboratory automation and the rising need for high-throughput diagnostic solutions have accelerated the demand for sophisticated instrumentation. These advanced instruments help reduce manual errors, enhance processing speed, and improve diagnostic accuracy, particularly in high-volume pathology labs. Additionally, the integration of digital imaging and artificial intelligence into pathology instruments is transforming traditional pathology practices, enabling remote slide analysis and enhancing collaboration among pathologists. 

Application Insights

The disease diagnosis segment accounted for the largest share of the market in 2024. This discipline plays a crucial role in the early detection, classification, and staging of a wide range of diseases, particularly cancer. By examining tissue and cell samples at the microscopic level, pathologists provide definitive diagnoses that guide therapeutic decisions and patient management strategies. The increasing prevalence of chronic illnesses, such as cardiovascular disorders, autoimmune diseases, and neurological conditions, is further fueling the demand for accurate and timely pathological evaluations.

The drug discovery and development is projected to exhibit the highest CAGR over the forecast period. Pharmaceutical and biotechnology companies rely heavily on tissue analysis and histopathological data to assess the safety and efficacy of new drug candidates during preclinical and clinical trials. Anatomic pathology helps identify biomarkers, understand disease mechanisms, and evaluate drug-induced tissue changes, which are critical for regulatory submissions and therapeutic validation. The integration of advanced imaging techniques and digital pathology has further enhanced the ability to conduct high-resolution tissue analysis, supporting more efficient and cost-effective drug development processes.

End Use Insights

The hospital segment accounted for the largest share of the market in 2024. These facilities handle a high volume of surgical and biopsy specimens that require pathological evaluation, particularly in departments such as oncology, surgery, and internal medicine. With the growing prevalence of chronic conditions and cancer-related procedures, hospitals rely heavily on in-house or affiliated pathology departments to ensure accurate and timely diagnostic results. The presence of advanced infrastructure, experienced pathologists, and integration with electronic health record systems allows hospitals to deliver comprehensive pathology services efficiently.

The diagnostic laboratories segment is expected to register the highest CAGR during the forecast period. These laboratories typically manage a large volume of specimens and are equipped with state-of-the-art equipment and skilled professionals to deliver high-precision results. Their growing importance is fueled by the increasing demand for cost-effective and scalable diagnostic solutions, especially in regions facing a shortage of pathologists or limited access to advanced pathology infrastructure. Diagnostic labs are also at the forefront of adopting digital technologies, enabling remote slide interpretation, AI-powered diagnostics, and cloud-based data management.

Top Companies in U.S. Anatomic Pathology Market

• Danaher Corporation
• Quest Diagnostics Incorporated
• Labcorp
• Agilent Technologies, Inc.
• Cardinal Health
• Sakura Finetek USA, Inc.
• NeoGenomics Laboratories, Inc.
• BioGenex
• Bio SB 

Market Segmentation

By Product & Services

• Instruments
  • Microtomes & Cryostat microtomes
  • Tissue processors
  • Automatic strainers
  • Whole Slide Imaging (WSI) Scanners
  • Other products
• Consumables
  • Reagents & Antibodies
  • Probes & Kits
  • Others
• Services

By Application

• Disease Diagnosis
• Drug Discovery and Development
• Others

By End Use 

• Hospitals
• Research Laboratories
• Diagnostic Laboratories
• Others